AAAAAA

   
Results: 1-9 |
Results: 9
SINGLE TUBE MULTIPLEX POLYMERASE-CHAIN-REACTION GENOTYPE ANALYSIS OF GSTM1, GSTT1 AND GSTP1 - RELATION OF GENOTYPES TO TP53 TUMOR STATUS AND CLINICOPATHOLOGICAL VARIABLES IN BREAST-CANCER PATIENTS
Authors: KRISTENSEN VN ANDERSEN TI ERIKSTEIN B GEITVIK G SKOVLUND E NESLAND JM BORRESENDALE AL
Citation: Vn. Kristensen et al., SINGLE TUBE MULTIPLEX POLYMERASE-CHAIN-REACTION GENOTYPE ANALYSIS OF GSTM1, GSTT1 AND GSTP1 - RELATION OF GENOTYPES TO TP53 TUMOR STATUS AND CLINICOPATHOLOGICAL VARIABLES IN BREAST-CANCER PATIENTS, Pharmacogenetics, 8(5), 1998, pp. 441-447
A RARE CYP19 (AROMATASE) VARIANT MAY INCREASE THE RISK OF BREAST-CANCER
Authors: KRISTENSEN VN ANDERSEN TI LINDBLOM A ERIKSTEIN B MAGNUS P BORRESENDALE AL
Citation: Vn. Kristensen et al., A RARE CYP19 (AROMATASE) VARIANT MAY INCREASE THE RISK OF BREAST-CANCER, Pharmacogenetics, 8(1), 1998, pp. 43-48
DOSAGE OF ADJUVANT G-CSF (FILGRASTIM) SUPPORTED FEC POLYCHEMOTHERAPY BASED ON EQUIVALENT HEMATOLOGICAL TOXICITY IN HIGH-RISK BREAST-CANCER PATIENTS
Authors: BERGH J WIKLUND T ERIKSTEIN B FORNANDER T BENGTSSON NO MALMSTROM P KELLOKUMPULEHTINEN P ANKER G BENNMARKER H WILKING N
Citation: J. Bergh et al., DOSAGE OF ADJUVANT G-CSF (FILGRASTIM) SUPPORTED FEC POLYCHEMOTHERAPY BASED ON EQUIVALENT HEMATOLOGICAL TOXICITY IN HIGH-RISK BREAST-CANCER PATIENTS, Annals of oncology, 9(4), 1998, pp. 403-411
HIGH-DOSE THERAPY OF STAGE-II BREAST-CANCER PATIENTS - TUMOR-CELL CONTAMINATION AND PURGING
Authors: KVALHEIM G PHARO A HOLTE H GILEN E ERIKSTEIN B NESLAND J
Citation: G. Kvalheim et al., HIGH-DOSE THERAPY OF STAGE-II BREAST-CANCER PATIENTS - TUMOR-CELL CONTAMINATION AND PURGING, Bone marrow transplantation, 21, 1998, pp. 203-203
EXPRESSION OF STROMELYSIN-3 IN MEDULLARY CARCINOMA OF THE BREAST
Authors: HOLM R FLORENES VA ERIKSTEIN B NESLAND JM
Citation: R. Holm et al., EXPRESSION OF STROMELYSIN-3 IN MEDULLARY CARCINOMA OF THE BREAST, Anticancer research, 17(5B), 1997, pp. 3725-3727
DETECTION OF MICROMETASTASIS IN BONE-MARROW AND BLOOD IN HIGH-RISK STAGE-II BREAST-CANCER PATIENTS
Authors: KVALHEIM G GILEN E ERIKSTEIN B HERVIG I PHARO A WIST E SOMMER H ANKER G TELHAUG R NESLAND J
Citation: G. Kvalheim et al., DETECTION OF MICROMETASTASIS IN BONE-MARROW AND BLOOD IN HIGH-RISK STAGE-II BREAST-CANCER PATIENTS, Blood, 90(10), 1997, pp. 948-948
PURGING OF BREAST-CANCER CELLS FROM LEUKAPHERESIS PRODUCTS
Authors: KVALHEIM G PHARO A FODSTAD O HOLTE H ERIKSTEIN B NESLAND L SMELAND E WANG MY
Citation: G. Kvalheim et al., PURGING OF BREAST-CANCER CELLS FROM LEUKAPHERESIS PRODUCTS, Blood, 88(10), 1996, pp. 994-994
FLOW CYTOMETRIC INVESTIGATION OF A POSSIBLE PRECURSOR-PRODUCT RELATIONSHIP BETWEEN OVAL CELLS AND PARENCHYMAL-CELLS IN THE RAT-LIVER
Authors: GERLYNG P GROTMOL T STOKKE T ERIKSTEIN B SEGLEN PO
Citation: P. Gerlyng et al., FLOW CYTOMETRIC INVESTIGATION OF A POSSIBLE PRECURSOR-PRODUCT RELATIONSHIP BETWEEN OVAL CELLS AND PARENCHYMAL-CELLS IN THE RAT-LIVER, Carcinogenesis, 15(1), 1994, pp. 53-59
BINUCLEATION AND POLYPLOIDIZATION PATTERNS IN DEVELOPMENTAL AND REGENERATIVE RAT-LIVER GROWTH
Authors: GERLYNG P ABYHOLM A GROTMOL T ERIKSTEIN B HUITFELDT HS STOKKE T SEGLEN PO
Citation: P. Gerlyng et al., BINUCLEATION AND POLYPLOIDIZATION PATTERNS IN DEVELOPMENTAL AND REGENERATIVE RAT-LIVER GROWTH, Cell proliferation, 26(6), 1993, pp. 557-565
Risultati: 1-9 |